[ad_1] Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be…
Tag:
Biopharmaceuticals
-
-
STOCK MARKET
This strategist warned investors not to chase momentum at the top. Now he says it’s time to be a contrarian.
by userby user[ad_1] Michael Darda, chief economist and market strategist at MKM Partners, was no fan of…
-
[ad_1] Merck & Co. MRK, +0.53% MRK, +2.29% is in advanced talks to acquire Seagen Inc. SGEN, -0.93%…
-
[ad_1] AstraZeneca PLC said Monday that its Enhertu drug has been recommended for approval in…
-
[ad_1] Ipsen said Monday that it has reached an agreement to acquire U.S. oncology drugmaker…
-
[ad_1] Valneva SE’s shares continue to trade higher on Tuesday following news that U.S. peer…
-
STOCK MARKET
U.S. to start vaccinating very young children this week, and panel to recommend overhauling health care system
by userby user[ad_1] The U.S. will start vaccinating children below the age of 5 starting this week,…
-
[ad_1] AstraZeneca PLC said Monday that its Covid-19 vaccine has been granted approval in the…
-
STOCK MARKET
How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid
by userby user[ad_1] Gilead Sciences Inc. GILD, -0.29% has steadily expanded the use of Veklury while much…
-
[ad_1] Amgen Inc. on Wednesday logged better-than-expected revenue and a decline in profit in the…